	Clinical outcomes of breast reconstruction using omental flaps: A systematic review. JPRAS Open Smit JM, Plat VD, van Est MLQ, van der Velde S, Daams F, Negenborn VL. PMID: 39279848 [PubMed - as supplied by publisher]
	ERAS-Based Anesthetic Management of Patients Undergoing Abdominal-Based Free Flap Breast Reconstruction: A Narrative Review. JPRAS Open Guo C, Lou F, Wu J, Zhang J. PMID: 39279847 [PubMed - as supplied by publisher]
	A Circadian Rhythm-related Signature to Predict Prognosis, Immunei Infiltration, and Drug Response in Breast Cancer. Curr Med Chem Chu M, Huang J, Wang Q, Fang Y, Cui D, Jin Y. PMID: 39279697 [PubMed - as supplied by publisher]
	Current approaches to the pharmacological management of metastatic breast cancer in older women. Expert Opin Pharmacother Carmona-Gonzalez CA, Kumar S, Menjak IB. PMID: 39279590 [PubMed - as supplied by publisher]
	Diagnostic Performance of Grayscale Ultrasonography in the Evaluation of Mass-forming Breast Lesions. Ann Afr Med Madhuri H, Aruna Devi M, Sravani G. PMID: 39279165 [PubMed - indexed for MEDLINE]
	New insights in breast cancer-related lymphedema. J Med Vasc Fourgeaud C, Vignes S. PMID: 39278693 [PubMed - indexed for MEDLINE]
	A Comprehensive Review of Current Treatment Modalities for Leptomeningeal Carcinomatosis in Breast Cancer. Crit Rev Oncol Hematol Morris CD, Humphrey C, Dillon P. PMID: 39278427 [PubMed - as supplied by publisher]
	Abemaciclib increases the risk of venous thromboembolism in breast cancer: Integrate meta-analysis, pharmacovigilance database analysis, and in vitro validation. Cancer Treat Rev Hua M, Xiong F, Chong S, Zhang Z, Liu Q, Hou J, Zhang Z, Gu Z, Cui X, Cui Y, Xu L, Xiang Q. PMID: 39278067 [PubMed - as supplied by publisher]
	Modified peri-areolar mastopexy and fat grafting in complex breast ptosis: A randomized open-label controlled trial. J Plast Reconstr Aesthet Surg Gentile P. PMID: 39277967 [PubMed - as supplied by publisher]
	A causal relationship between bone mineral density and breast cancer risk: a mendelian randomization study based on east Asian population. BMC Cancer Cheng Z, Xu H, Wang X, Teng T, Li B, Cao Z, Li Z, Zhang J, Xuan J, Zhang F, Chen Y, Li Y, Wang W. PMID: 39277718 [PubMed - indexed for MEDLINE]
	Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med Shatsky RA, Trivedi MS, Yau C, Nanda R, Rugo HS, Davidian M, Tsiatis B, Wallace AM, Chien AJ, Stringer-Reasor E, Boughey JC, Omene C, Rozenblit M, Kalinsky K, Elias AD, Vaklavas C, Beckwith H, Williams N, Arora M, Nangia C, Roussos Torres ET, Thomas B, Albain KS, Clark AS, Falkson C, Hershman DL, Isaacs C, Thomas A, Tseng J, Sanford A, Yeung K, Boles S, Chen YY, Huppert L, Jahan N, Parker C, Giridhar K, Howard FM, Blackwood MM, Sanft T, Li W, Onishi N, Asare AL, Beineke P, Norwood P, Brown-Swigart L, Hirst GL, Matthews JB, Moore B, Symmans WF, Price E, Heditsian D, LeStage B, Perlmutter J, Pohlmann P, DeMichele A, Yee D, van 't Veer LJ, Hylton NM, Esserman LJ. PMID: 39277672 [PubMed - as supplied by publisher]
	Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med Khoury K, Meisel JL, Yau C, Rugo HS, Nanda R, Davidian M, Tsiatis B, Chien AJ, Wallace AM, Arora M, Rozenblit M, Hershman DL, Zimmer A, Clark AS, Beckwith H, Elias AD, Stringer-Reasor E, Boughey JC, Nangia C, Vaklavas C, Omene C, Albain KS, Kalinsky KM, Isaacs C, Tseng J, Roussos Torres ET, Thomas B, Thomas A, Sanford A, Balassanian R, Ewing C, Yeung K, Sauder C, Sanft T, Pusztai L, Trivedi MS, Outhaythip A, Li W, Onishi N, Asare AL, Beineke P, Norwood P, Brown-Swigart L, Hirst GL, Matthews JB, Moore B, Fraser Symmans W, Price E, Beedle C, Perlmutter J, Pohlmann P, Shatsky RA, DeMichele A, Yee D, van 't Veer LJ, Hylton NM, Esserman LJ. PMID: 39277671 [PubMed - as supplied by publisher]
	ViT-MAENB7: An innovative breast cancer diagnosis model from 3D mammograms using advanced segmentation and classification process. Comput Methods Programs Biomed Umamaheswari T, Babu YMM. PMID: 39276667 [PubMed - as supplied by publisher]
	Factors impacting breast cancer survivors' performance of annual follow-up mammograms: A nationally representative study. Patient Educ Couns Elkefi S, Matthews AK. PMID: 39276442 [PubMed - as supplied by publisher]
	Clinical benefit and safety profile of cross-line therapy with CDK4/6 inhibitors: a retrospective study of HR+/HER2- advanced breast cancer. Cancer Biol Med Zhao Q, Jiang M, Liu J, Zhang M, He M, Zhou S, Wang J, Mo H, Lan B, Yuan P, Zhang P, Ma F, Li Q, Xu B. PMID: 39267478 [PubMed - as supplied by publisher]
	Women's Lived Experiences in the Use of Complementary and Alternative Medicine for Breast Cancer Management: A Phenomenological Study. J Holist Nurs Christina J, Abigail W, De Bellis A, Harrington A. PMID: 39267386 [PubMed - as supplied by publisher]
	Prevalence and impact of metabolic associated fatty liver disease in non-metastatic breast cancer women at initial diagnosis: a cross-sectional study in China. Clin Transl Oncol Jiang ZY, Liang XY, Hu L, Ran L, She RL, Ma CY, Feng JH, Song JY, Li ZX, Qu XQ, Peng BQ, Wu KN, Kong LQ. PMID: 39276288 [PubMed - as supplied by publisher]
	Correction to: Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study. Cancer Med PMID: 39275877 [PubMed]
	Proton therapy for breast cancer: Reducing toxicity. Thorac Cancer Qiao K, Wei Y, Tao C, Zhu J, Yuan S. PMID: 39275876 [PubMed - as supplied by publisher]
	An Electrochemical Nucleic Acid Biosensor for Triple-Negative Breast Cancer Biomarker Detection. Sensors (Basel) Hansen L, Nagdeve SN, Suganthan B, Ramasamy RP. PMID: 39275659 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 196488

Page 1 of 9825



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy